Physician profile
Elisa Bianchi
NPI 1689017303
$8,003.81
in general payments reported to CMS, 2019-2025
17 companies · $907 in 2025
The $907 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,172 · 2020: $355 · 2021: $244 · 2022: $298 · 2023: $1,997 · 2024: $1,031 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746 · Travel and Lodging: $1,181 · Education: $1,000 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.99 |
| Travel and Lodging | $1,180.72 |
| Education | $1,000.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,665.42 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic USA, INC. | $1,410.92 | 2019-2020 | |
| Acera Surgical, INC. | $335.03 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $287.64 | 2022-2025 | Signia, Ligasure |
| Boston Scientific Corporation | $253.69 | 2019-2025 | Axonics |
| Thd America, INC. | $211.64 | 2022-2023 | |
| Dilon Technologies, INC. | $180.66 | 2022-2024 | Hemoblast Bellows |
| Ironwood Pharmaceuticals, INC | $124.96 | 2019 | |
| Mimedx Group, INC. | $112.03 | 2025 | |
| Ethicon US, LLC | $108.48 | 2025 | Echelon Circular |
| Regeneron Healthcare Solutions, INC. | $97.28 | 2023 | Dupixent |
| Solventum Corporation | $85.69 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Aroa Biosurgery Incorporated | $39.53 | 2024-2025 | |
| Vioptix INC | $31.34 | 2021 | |
| Axonics, INC. | $21.33 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $19.49 | 2020 | |
| Braintree Laboratories, INC. | $18.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisa Bianchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.